- Home
- VNDA vs NCA Comparison
VNDA vs NCA Comparison
Compare VNDA & NCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- NCA
- Stock Information
- Founded
- VNDA 2002
- NCA 1987
- Country
- VNDA United States
- NCA United States
- Employees
- VNDA N/A
- NCA N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- NCA Investment Managers
- Sector
- VNDA Health Care
- NCA Finance
- Exchange
- VNDA Nasdaq
- NCA Nasdaq
- Market Cap
- VNDA 237.9M
- NCA N/A
- IPO Year
- VNDA 2006
- NCA N/A
- Fundamental
- Price
- VNDA $4.22
- NCA $8.64
- Analyst Decision
- VNDA Strong Buy
- NCA
- Analyst Count
- VNDA 2
- NCA 0
- Target Price
- VNDA $16.50
- NCA N/A
- AVG Volume (30 Days)
- VNDA 500.0K
- NCA 59.6K
- Earning Date
- VNDA 05-07-2025
- NCA 01-01-0001
- Dividend Yield
- VNDA N/A
- NCA 3.92%
- EPS Growth
- VNDA N/A
- NCA N/A
- EPS
- VNDA N/A
- NCA N/A
- Revenue
- VNDA $201,351,000.00
- NCA N/A
- Revenue This Year
- VNDA $14.36
- NCA N/A
- Revenue Next Year
- VNDA $44.53
- NCA N/A
- P/E Ratio
- VNDA N/A
- NCA N/A
- Revenue Growth
- VNDA 13.37
- NCA N/A
- 52 Week Low
- VNDA $3.85
- NCA $7.77
- 52 Week High
- VNDA $6.75
- NCA $9.12
- Technical
- Relative Strength Index (RSI)
- VNDA 41.17
- NCA 62.72
- Support Level
- VNDA $4.20
- NCA $8.42
- Resistance Level
- VNDA $4.64
- NCA $8.58
- Average True Range (ATR)
- VNDA 0.17
- NCA 0.09
- MACD
- VNDA 0.01
- NCA 0.03
- Stochastic Oscillator
- VNDA 20.75
- NCA 100.00
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.